Exclusive

Publication

Byline

Double whammy: Regulatory hurdles, one-time expenses erase half of Cipla profit

Cipla Q3 Results, Jan. 23 -- Pharma major Cipla posted a massive 57% year-on-year (y-o-y) decline in its consolidated net profit for the third quarter of the ongoing fiscal on Friday, missing estimate... Read More